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Abstract— Development of a panel of monoclonal 
antibodies against triad junctional membranes provided a 
powerful tool for the characterisation of multiple proteins 
participating in excitation-contraction coupling (ECC), 
including the ryanodine receptor (RyR) calcium channel, 
dihydropyridine receptor voltage-sensor and linker protein 
triadin.  Another component of ECC, termed the 90 kDa 
junctional foot protein (JFP90/JSR90) was identified with 
an antibody clone, mAb VF1c.   This protein is 
predominantly expressed in skeletal muscle, is most 
abundant in fast-twitch fibres and is phosphorylated by an 
endogenous kinase.  Additional studies indicated that it 
forms a supramolecular complex with the RyR and is 
upregulated in muscles from aged humans.  Despite its 
potential importance, the molecular identity of JFP90 was 
not determined at the time.  In the current study, the 
identity of JFP90/JSR90 was deduced by 
immunoprecipitation with mAb VF1c and proteomic 
analysis of the major proteins isolated.  Using this approach, 
it was determined that JFP90 is junctophilin 1, a 
triad-enriched protein that links the sarcoplasmic 
reticulum to the t-tubules, thereby contributing to ECC.  
Consolidated with data from previous publications, the 
current study reveals novel properties of junctophilin 1, in 
particular that it is selectively upregulated in the soleus 
muscle, but not quadriceps, of aged mice.   
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I. INTRODUCTION 
N skeletal muscle, communication between voltage-sensing 
dihydropyridine receptors (DHPR) in the t-tubular system 
and ryanodine receptor (RyR) calcium release channels in the 
terminal cisternae of the sarcoplasmic reticulum (TC-SR) is 
critical for excitation-contraction coupling (ECC),  for review 
see [1].  Triad junctions represent couplings between the 
t-tubular and the TC-SR membranes and are highly enriched in 
proteins participating in ECC.  A milestone in the 
understanding of the biochemistry of this process was the 
generation of a panel of monoclonal antibodies by 
immunisation of mice with purified triad junction membranes.  
Antibodies produced using this approach proved invaluable for 
the characterisation of multiple proteins involved in ECC, 
including the DHPR [2], RyR [3] and the junctional 
glycoprotein triadin [4]. 
 One clone from this library, monoclonal antibody (mAb) 
VF1c, recognises a component termed the 90 kDa junctional 
foot protein (JFP90) or the 90 kDa junctional SR protein 
(JSR90).  This membrane protein is highly enriched in the triad 
junctions, is phosphorylated by an endogenous kinase, is 
exclusively detected in skeletal muscle and not in other tissues, 
and is most abundant in type 2 fast-twitch fibres [5].   
Expression of JFP90 is markedly reduced in canine muscles 
treated by chronic low-frequency electrical stimulation, used as 
a model of fast-slow fibre type transition [6].  Chemical 
cross-linking studies suggested that JFP90 forms a 
supramolecular complex with the RyR and so, is potentially 
involved in the regulation or organisation of ECC [7].   Using 
mAb VF1c to probe immunoblots of vastus lateralis samples 
from male humans ranging in age from 47 to 73 years old, it 
was qualitatively demonstrated that JFP90 is upregulated in 
aged muscles [8].  Since the efficiency of ECC is reduced in 
flexor digitorum brevis myofibres from old (20-22 month) 
compared with young (3-6 months) mice [9], increased JFP90 
expression might participate in the pathology of sarcopenia, or 
might be a compensatory response to it.  Given the public 
health impact of age-related declines in muscle performance 
[10], understanding the roles of JFP90 in skeletal muscle is of 
scientific and medical merit. 
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 A major limitation in understanding the function of JFP90 
has been the failure to deduce its molecular identity.  In the 
current study, in order to address this deficiency, mAb VF1c 
was used to immunoprecipitate JFP90 from solubilised rabbit 
back muscle membranes.  Proteomic analyses of two major 
proteins isolated, of apparent molecular weight 90 kDa and 68 
kDa, indicated that they are full-length and truncated forms of 
junctophilin 1 (JPH1), a triad junction-enriched SR membrane 
protein that links TC-SR to the t-tubular system [11, 12].  
Epitope mapping indicated that mAb VF1c binds to a region 
between residues 369 and 460 of 662 amino acid protein.  
These findings are consistent with the notion that JPH1 is 
cleaved by endogenous calcium-dependent proteases, or 
calpains [13].   
 The current investigation also found that JPH1 was 
upregulated in soleus muscle from old (25 month) compared 
with adult (12 month) mice, but its expression levels were 
indistinguishable between the two age groups in quadriceps.  
Overall, this work links previous biochemical data about JFP90 
to JPH1, highlighting unexplored avenues for exploration of the 
biology of this protein.  For example, JFP90 (and therefore 
JPH1) is phosphorylated by an endogenous kinase, but the 
mechanisms and functional consequences of this have not been 
investigated to date.  ‘Filling-the-gaps’ approaches to 
consolidation of scientific knowledge, such as that presented 
here, are likely to become increasingly important in the near 
future, given the vast and expanding quantity of data that are 
available via the internet and other resources.  Part of this work 
has been presented in oral form at the Royal Academy of 
Medicine in Ireland (RAMI), Biomedical Section Meeting at 
University College Cork, 20
th
 June 2013. 
II. METHODS 
2.1.  Materials 
 
 Protease inhibitors, materials for SDS-PAGE, 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate 
hydrate (CHAPS, >98%), anti-smooth muscle myosin  mAb 
hSM-V, horse-radish peroxidase conjugated secondary 
antibodies and general reagents were from Sigma-Aldrich 
Ireland Ltd. (Arklow, Co. Wicklow, Ireland).  Dynal Protein G 
paramagnetic beads and a rabbit polyclonal antibody (pAb 
anti-JP1) generated against a C-terminal peptide from JPH1 
were purchased from Bio-Sciences Limited (Dun Laoghaire, 
Co. Dublin, Ireland).  An antibody recognising JFP90, mAb 
VF1c, was obtained from Novus Biologicals, (Littleton, USA).    
 
2.2.  Animals 
 
 All animal procedures were carried out in accordance with 
local procedures, approved by the appropriate ethics 
committees.  Experiments on the effects of ageing on muscle 
expression of JFP90 were performed in accordance with UK 
Home Office Guidelines under the Animals (Scientific 
Procedures) Act 1986.  Male C57Bl/6 mice were housed in a 
temperature controlled environment with a 12 h light-dark 
cycle and were fed ad libitum on a standard laboratory chow.  
Animals were maintained to an age of either 12 months (‘adult’) 
or 25 months (‘old’), then were initially anesthetised using 100 
µL of Dormitor (0.15 mg/mL) and Ketaset (20 mg/mL), prior to 
sacrifice using cervical dislocation. 
 
2.3.  Preparation of tissue lysates and microsomal membranes 
 
 For the preparation of lysates, tissue samples were quickly 
excised and flash-frozen in liquid nitrogen.  They were 
subsequently thawed in 10 volumes per wet weight of modified 
RIPA buffer containing 150mM NaCl, 1% NP-40, 0.5% 
sodium deoxycholate, 0.1% SDS, 200mM NaF with freshly 
added protease inhibitors (1 g/mL aprotinin, leupeptin, 
pepstatin A and 0.5 mM phenylmethylsulfonyl fluoride 
(PMSF)) and homogenised on ice with 3 by 30 s bursts of an 
Ultraturrex disperser, fitted with a T-25 probe. Insoluble 
material was removed via centrifugation at 12,000 g for 30 min 
at 4˚C.   Microsomal membranes, enriched in SR, were 
prepared from rabbit back muscle by differential 
ultracentrifugation, as described previously [14].  All samples 
were divided into 0.5 mL aliquots, flash-frozen in liquid 
nitrogen and stored at -80
o
C until use. 
 
2.4.   Solubilisation, immunoprecipitation and proteomics 
 
 Rabbit skeletal muscle microsomes (4 mg protein/reaction) 
were solubilised in 2 mL of 2% CHAPS, 0.5 M NaCl, 0.5 mM 
PMSF, 20 mM Tris-HCl pH7.4 for 1h on a shaking platform at 
room temperature (18-22
o
C).  Samples were then diluted in 8 
mL/reaction of ice-cold 0.5 mM PMSF, 20 mM Tris-HCl 
pH7.4, prior to being centrifuged to clear insoluble material 
(113,000 g, Beckman Type 65 rotor for 1 h, 4
o
C).  Supernatants 
were incubated with 50 L of Dynal Protein G paramagnetic 
beads pre-bound to 5 L of either mAb VF1c or mAb hSM-V 
(anti-smooth muscle myosin, as an isotype matched negative 
control) ascites fluid, according to the manufacturer’s 
instructions.  Following incubation for 1h at room temperature 
on a shaking platform, immune complexes bound to 
paramagnetic beads were collected using a magnetic separator 
and were resuspended in 1 mL of ice-cold 0.1% CHAPS, 0.5 
mM PMSF, 20 mM Tris-HCl pH7.4.  Following another three 
wash steps, paramagnetic beads were resuspended in 50 L of 2 
x concentrated sample buffer (1.6 % SDS, 8% glycerol, 0.04 % 
bromophenol blue, 4 mM dithiothreitol, 50 mM Tris-HCl 
pH6.8) and were heated to 95
o
C for 5 min prior to separation on 
7.5% SDS-PAGE minigels.  Following staining with 
Coomassie R250, major bands in the mAb VF1c 
immunoprecipitate were excised and analysed using a 
commercial MALDI-MS and MS/MS protein identification 
service (Proteomics service, Technology Facility, Department 
of Biology, University of York, UK).  Parallel blots were 
transferred to polyvinylidene fluoride (PVDF) prior to 
immunostaining with mAb VF1c, as described in Section 2.6.  
Identification of potential PEST motifs in target proteins was 
determined using ‘epestfind’ software at 
(http://emboss.bioinformatics.nl/cgi-bin/emboss/epestfind/).  
PEST motifs target proteins for degradation by 
calcium-dependent proteases, or calpains [15].  A PEST score 
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of greater than +5 indicated that the potential motif was 
considered ‘of interest’.  
 
2.5.  Epitope mapping of mAb VF1c 
 
 In order to determine the site of interaction of mAb VF1c 
with JPH1, cDNA constructs encoding overlapping fragments 
of this protein were heterologously expressed in yeast [16], 
using protocols essentially the same as those described 
previously for ankyrin-1 [17].  The JPH1 clones corresponded 
to the following amino acid residues of human JPH1: JP1A: 
1-233, JP1B: 232-369, JP1C:369-571, JP1D: 141-278, 
JP1G:  229-460, JP1L: 154-278, JP1M: 229-550, JP1Delta: 
154-635.  These proteins were resolved on 10% SDS-PAGE 
minigels, transferred to PVDF and immunostained with mAb 
VF1c or pAb JP1 as described in Section 2.6.   To further define 
the mAb VF1c epitope within the region identified by screening 
yeast fusion proteins, peptide arrays of overlapping 18-mers 
were generated, essentially as described previously [18].  
 
2.6.  General protein methods 
 
 Protein concentrations were determined using the Bradford 
assay [19], using bovine serum albumin as a standard.  
Quantities of protein loaded onto SDS-PAGE minigels are 
noted in the figure legends.  Western transfer and 
immunostaining of proteins with mAb VF1c (1:1500 dilution ) 
or  pAb JP1 (1:1000) were performed as described previously 
[20].   Following immunostaining, PVDF blots were stained 
with Coomassie R250 as a protein loading control, essentially 
as described by Welinder and Ekblad [21]. 
 
2.7.  Statistical methods 
 
 For quantification of protein expression, images of 
immunostained or Coomassie R250 stained PVDF membranes 
were captured using a gel documentation system and exported 
as JPEG files.  The densities of immunoreactive bands, or of 
total protein in each lane, were determined using NIH ImageJ 
software (http://rsbweb.nih.gov/ij/).  The density of each 
immunoreactive band was divided by the total protein density 
in that lane and the mean values of these ratios in tissue from 
young animals was taken as 100%, for comparisons with 
corresponding tissues from old mice.  These mean normalised 
band densities were compared using one-way ANOVA with 




3.1.  JFP90/JSR90 is Junctophilin-1 
 
 In order to determine the primary structure of JFP90/JSR90, 
microsomal membranes from rabbit back muscle were 
solubilised and  immunoprecipitated using mAb VF1c.  Several 
proteins were immunoprecipitated by mAb VF1c, but not by an 
isotype-matched negative control mAb, Fig. 1, ‘Coomassie 
R250’.  These include proteins with apparent molecular weights 
of >300 kDa, 170 kDa, 111 kDa, 90 kDa, 68 kDa and 22 kDa.  
Of these proteins, only the 90 kDa (‘Band I’) and 68 kDa 
(‘Band II’) were immunostained with mAb VF1c on a parallel 
western blot, Fig. 1, ‘mAb VF1c’.  Immunoprecipitation 
facilitated major enrichment of the mAb VF1c interacting 
proteins, since these represented minor components of 
solubilised muscle microsomes, which were not detectable in 
the solubilised material by immunoblot under these conditions.  
This purification step permitted proteomic identification of 
JFP90/JSR90 using a commercial service.  Both Band I and 
Band II were good matches to rabbit junctophilin-1 (JPH1), in 
terms of MOWSE scores (230 and 116) and coverage, Fig. 2C.   
The bands had three JPH1 peptides in common (residues 84-91, 
145-156 and 304-313), but Band I contained an additional, 
more C-terminal peptide (558-573).  This suggests that Band II 
might represent the product of proteolytic cleavage of 
full-length JPH1, Band I.  Since JPH1 is reported to be cleaved 
by calcium-dependent proteases in rat skeletal muscle [13], the 
presence of calpain cleavage sites, or PEST motifs, in rabbit 
JPH1 was examined using epestfind software.  This identified 
one strong potential PEST motif, with a score of +12.35 (the 
threshold value is +5), between residues 458 and 471, Fig. 2C.  
Calpain cleavage of 72 kDa full-length JPH1 at this site would 
generate products of 50 kDa and 22 kDa.  Although these 
calculated molecular weights do not match those determined 
experimentally (90 kDa full-length, 68 kDa product), possibly 
because of the highly basic amino acid composition (predicted 
isoelectric point of full-length JPH1= 9.4; note the anomalous 
migration of JPH1 fusion proteins in Fig. 2A and 2B), the 22 
kDa shift in molecular weight is as predicted, Fig. 2C.  This 
also raises the possibility that the minor 22 kDa protein 
immunoprecipitated by mAb VF1c is the C-terminal calpain 
cleavage product of JPH1.  Attempts to verify this by western 
blotting of the mAb VF1c immunoprecipitates with an 
anti-JPH1 antibody raised against a C-terminal peptide were 
unsuccessful, due to low signal-to-noise ratios on these blots 
(not shown). 
 
Fig. 1.  Immunoprecipitation and proteomics of JFP90 reveals that it is JPH1. 
Rabbit back muscle microsomes were CHAPS-solubilised and 
immunoprecipitated with either mAb VF1c (anti-JFP90, ‘IP VF1c) or an 
isotype-matched negative control (‘IP –ve’).  Immunoprecipitates and 
solubilised starting material were then resolved on 7.5% SDS-PAGE minigels 
and either stained with Coomassie R250, or transferred to PVDF membranes by 
western blotting and immunostained with mAb VF1c.  Immunoreactive protein 
bands (‘Band I’ and ‘II’) were excised from the Coomassie stained gels for 
protein identification.  Data shown are representative of three separate 
experiments. 
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3.2 Mapping of the epitope for mAb VF1c. 
 
 To map the location of the epitope for mAb VF1c within the 
primary structure of JPH1, thereby confirming that JFP90 and 
this protein are identical, overlapping segments of this protein 
were overexpressed in yeast and probed with the antibody on 
western blots.  The anti-JFP90 antibody was strongly 
immunoreactive with fusion proteins corresponding to residues 
229-460, 229-550 and 154-635 of human JPH1, but also 
recognised a polypeptide spanning amino acid 369-571, Fig. 
2A.  This indicates that mAb VF1c recognises a segment 
spanning residues 369-460 of human JPH1, corresponding to a 
divergent/-helical region within this protein that has been 
postulated to play a role in determining the width of the gap 




Fig. 2.  The region from residues 369-460 of human JPH1 contains the epitope 
of mAb VF1c.  A.  Fragments of human JPH1 were overexpressed in yeast, 
resolved by SDS-PAGE and immunoblotted with mAb VF1c.  The asterisk (*) 
indicates a protein present in yeast that was detected in the ‘Vector’ only 
transfected sample.  B.  A parallel blot was probed with a commercial rabbit 
antiserum directed against a C-terminal peptide from JPH1.  C.  Diagram 
summarising the relative positions of peptides derived from 
immunoprecipitated JFP90 (match from Band I only in grey font), the positions 
of the epitopes of mAb VF1c and anti-JP1 antiserum and the location of a 
potential calpain cleavage site, or PEST motif. 
  
 In attempts to further define the epitope of mAb VF1c, an 
array of overlapping 18-mer peptides was constructed that 
corresponded to this region.  However, signals detected by 
mAb VF1c on such arrays did not qualitatively differ from 
those probed with secondary antibody alone, Fig. 3, suggesting 
that this antibody might recognise an epitope that is dependent 
on higher order structure within the protein.  As anticipated, a 
C-terminally directed commercial anti-JPH1 antiserum only 
bound to a fusion protein containing the C-terminus of this 
protein, ‘Delta:154-635’,  Fig. 2B.  The relative positions of the 
mAb VF1c and anti-JP1 are shown in the diagram in Fig. 2C, 
along with the peptide sequences deduced from proteomic 




Fig. 3.  Mapping of the mAb VF1c epitope using peptide arrays. Overlapping 
18-mer peptide spots (1-26) covering residues 369-460 of rabbit junctophilin 1 
(NCBI Accession Number: NP_001075465.1) were synthesised in duplicate on 
two arrays.  One array, A, was probed with a 1:500 dilution of mAb VF1c,  
followed by washing then a 1:2500 of LiCor goat anti-mouse IgG IRDye 
680LT conjugated secondary antibody.  A parallel array, B, was probed with 
secondary antibody only.  Immunoreactive spots were detected using a LiCor 
Odyssey scanner.  Data are representative of two separate experiments.  The 
sequences of peptides are available on request. 
 
3.3.  During ageing, junctophilin-1 is significantly upregulated 
in mouse soleus but not in quadriceps. 
 
 
Fig. 4.  JP1 is upregulated in soleus, but not quadriceps, muscle from old mice. 
A.  Immunoblots of lysates (30 g protein/lane) from ‘Adult’ (12 months, n = 6) 
or ‘Old’ (25 month, n =5) mouse quadriceps (‘Quad’) or soleus muscle, probed 
using mAb VF1c.  Each blot was post stained with Coomassie R250 to estimate 
protein loading.  B.  Band densities from the immunoblots in Panel A were 
normalised to protein loading and expressed relative to the Adult group of 
animals for each muscle type.  JPH1 protein expression was significantly 
upregulated in the soleus of old mice (p =0.02 by one-way ANOVA and 
Tukey’s post-hoc test), but not in quadriceps.  Data are representative of two 
technical replicates.   
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 Qualitative data from another laboratory indicated that 
JFP90, demonstrated to be JPH1 in the current work, is 
upregulated with ageing in human vastus lateralis muscle [8].  
To examine this further, expression levels of JPH1 protein from 
quadriceps or soleus muscle from ‘adult’ and ‘old’ mice were 
assessed by western blotting using mAb VF1c.  Qualitatively, 
mouse quadriceps (‘Quad’) muscle expresses greater quantities 
of JPH1 than soleus (‘Soleus’), Fig. 4A.  There was an apparent 
upregulation of JPH1 in old animals in the soleus, but not in the 
quadriceps.  To quantify alterations in JPH1 protein expression 
with ageing, band densities were normalised to total protein by 
post hoc Coomassie R250 staining of PVDF membranes.  This 
demonstrated that soleus muscle from old mice expressed 
significantly greater levels of JPH1 protein than adult animals 
(240 + 50% (n = 5, mean + standard error) versus 100 + 30 % (n 
= 6); p = 0.02), whereas its abundance was not significantly 




 The data presented here strongly support the notion that 
JFP90, a protein whose molecular identity was unknown, is 
JPH1.  This permits unification of data relating to JFP90 to that 
on JPH1.  For example, JFP90 and therefore JPH1, is 
upregulated with age in human vastus lateralis muscle [8].  A 
study published by Brooks and Faulkner in 1988 [22] revealed 
that the contractile properties of soleus fibres were preserved 
between adult (9-10 months) and old (25 month) mice, whereas 
extensor digitorum longus (EDL) fibres from aged animals 
displayed significant reductions in specific maximum tetanic 
force.  In particular, ageing was associated with a prolongation 
of isometric twitch duration and a leftward shift in the 
frequency-force relationship in soleus, but not in EDL muscles.  
The authors speculated that these compensatory changes in 
soleus fibres could be related to alterations in Ca
2+-
handling.  
JPH1 plays a key role in muscle Ca
2+
 signalling, linking the 
DHPR voltage-sensor to other ECC components [16].  
Transgenic mice lacking JPH1 expression exhibit no suckling 
and early postnatal death, decreased formation of triad 
junctions  and reduced electrically evoked force production in 
muscle fibres [23].  Furthermore, shRNA-mediated 
downregulation of both JPH1 and JPH2 in C2C12 cell 
myotubes resulted in decreased Ca
2+
 transients in response to 





-release, leading to chronic Ca
2+
-store depletion [24].  
Decreased JPH1 protein expression is also associated with 
early deficits in strength that occur within three days of 
eccentric exercise [25].  In addition, reduced JPH1 levels have 
been linked with muscle weakness that occurs in the murine 
mdx model of muscular dystrophy [13].  Together with the 
current findings, these studies suggest that upregulation of 
JPH1 in soleus muscle from aged mice represents a 
compensatory mechanism, to enhance triad junction density, 
sarcoplasmic reticulum Ca
2+
-loading and force production [8].  
It was unexpected that JPH1 was not detectably altered in 
mouse quadriceps, given that this muscle group contains the 
vastus lateralis, in which this protein is upregulated with ageing 
in humans.  This distinction could relate to differences in 
muscle physiology between mice and humans, or to the other 
muscle groups present in the quadriceps. 
 Other aspects of JPH1 biology unveiled by its relationship to 
JFP90 include that it is phosphorylated by an endogenous 
kinase in skeletal muscle [5].  This indicates that JPH1 function 
might be modulated by phosphorylation, an aspect that awaits 
exploration.   In different muscle types, JFP90 has been 
detected as either a single major protein (for example, mouse 
quadriceps, Fig. 3A), or a doublet (rabbit back muscle, Fig. 1), 
also see references [6] and [7].  Given that JPH1 can be cleaved 
by calpains [13] at a site within the -helical linker region, 
proteolysis might serve as another mechanism for tissue- and 
activity-dependent regulation of this protein. 
 This project was initiated by expertise-based identification of 
a gap in the knowledge of ECC, namely the molecular identity 
of JFP90.  Similar approaches will be particularly timely, given 
the quantities of scientific data and literature that are currently 
available via internet accessible databases.  Such data mining 
and integration methods are amenable to automation, which has 
already been implemented to identify knowledge gaps in 
diverse fields, including in the characterisation of red algal 
evolution [26] and in construction of  protein phosphorylation 
networks [27].  Application of related strategies to different 
areas is likely to open fruitful avenues of scientific discovery.  
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